International Stroke Conference 2025  /  Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)
Logo

American Heart Association

International Stroke Conference 2025

Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)

ISC Invited Symposium

Hall H&J, AHA HeadQuarters, Neuro Talk Theater

Feb 5th , 03:15 PM - 03:35 PM

Showing 1 Result.